摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3R,4R,5R)-2-(2-acetyl-3-hydroxyphenoxy)-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate | 1133352-90-5

中文名称
——
中文别名
——
英文名称
(2S,3R,4R,5R)-2-(2-acetyl-3-hydroxyphenoxy)-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate
英文别名
——
(2S,3R,4R,5R)-2-(2-acetyl-3-hydroxyphenoxy)-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate化学式
CAS
1133352-90-5
化学式
C34H28O10
mdl
——
分子量
596.59
InChiKey
CUQWFHPIERYGAO-WIFIACMTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.01
  • 重原子数:
    44.0
  • 可旋转键数:
    10.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    134.66
  • 氢给体数:
    1.0
  • 氢受体数:
    10.0

反应信息

  • 作为反应物:
    描述:
    (2S,3R,4R,5R)-2-(2-acetyl-3-hydroxyphenoxy)-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoatesodium methylate 作用下, 以 甲醇 为溶剂, 反应 5.0h, 以14%的产率得到2',6'-dihydroxyacetophenone 2'-O-β-D-ribofuranoside
    参考文献:
    名称:
    Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors
    摘要:
    Nucleoside transporter inhibitors have potential therapeutic applications as anticancer, antiviral, cardio-protective and neuroprotective agents. Although quite a few potent inhibitors of the equilibrative nucleoside transporters are known, largely missing are the concentrative nucleoside transporter inhibitors. Phloridzin (3, K-i = 16.00 mu M) is a known moderate inhibitor of the concentrative nucleoside transporters. We have synthesized and evaluated analogs of phloridzin at the hCNT3 nucleoside transporter. Within the series of synthesized analogs compound 16 (K-i = 2.88 mu M), possessing a ribofuranose sugar unit instead of a glucopyranose as present in phloridzin, exhibited the highest binding affinity at the hCNT3 transporter. Phloridzin and compound 16 have also been shown to be selective for the hCNT3 transporter as compared with the hENT1 transporter. Compound 16 can serve as a new lead which after further modi. cations could yield selective and potent hCNT3 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.11.112
  • 作为产物:
    描述:
    2,6-二羟基苯乙酮2,3,5-tri-O-benzoyl-D-ribofuranosyl bromide 在 sodium hydride 作用下, 以 四氢呋喃 为溶剂, 反应 18.0h, 以6%的产率得到(2S,3R,4R,5R)-2-(2-acetyl-3-hydroxyphenoxy)-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate
    参考文献:
    名称:
    Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors
    摘要:
    Nucleoside transporter inhibitors have potential therapeutic applications as anticancer, antiviral, cardio-protective and neuroprotective agents. Although quite a few potent inhibitors of the equilibrative nucleoside transporters are known, largely missing are the concentrative nucleoside transporter inhibitors. Phloridzin (3, K-i = 16.00 mu M) is a known moderate inhibitor of the concentrative nucleoside transporters. We have synthesized and evaluated analogs of phloridzin at the hCNT3 nucleoside transporter. Within the series of synthesized analogs compound 16 (K-i = 2.88 mu M), possessing a ribofuranose sugar unit instead of a glucopyranose as present in phloridzin, exhibited the highest binding affinity at the hCNT3 transporter. Phloridzin and compound 16 have also been shown to be selective for the hCNT3 transporter as compared with the hENT1 transporter. Compound 16 can serve as a new lead which after further modi. cations could yield selective and potent hCNT3 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.11.112
点击查看最新优质反应信息